Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H12ClNO3 |
| Molecular Weight | 229.66 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](OC(N)=O)[C@@H](O)C1=CC=CC=C1Cl
InChI
InChIKey=TZOWVYPYWJLZTK-IMTBSYHQSA-N
InChI=1S/C10H12ClNO3/c1-6(15-10(12)14)9(13)7-4-2-3-5-8(7)11/h2-6,9,13H,1H3,(H2,12,14)/t6-,9+/m0/s1
| Molecular Formula | C10H12ClNO3 |
| Molecular Weight | 229.66 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 13:05:26 GMT 2023
by
admin
on
Sat Dec 16 13:05:26 GMT 2023
|
| Record UNII |
D7NM51C3GU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
555216
Created by
admin on Sat Dec 16 13:05:26 GMT 2023 , Edited by admin on Sat Dec 16 13:05:26 GMT 2023
|
||
|
FDA ORPHAN DRUG |
528216
Created by
admin on Sat Dec 16 13:05:26 GMT 2023 , Edited by admin on Sat Dec 16 13:05:26 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1353949-71-9
Created by
admin on Sat Dec 16 13:05:26 GMT 2023 , Edited by admin on Sat Dec 16 13:05:26 GMT 2023
|
PRIMARY | |||
|
D7NM51C3GU
Created by
admin on Sat Dec 16 13:05:26 GMT 2023 , Edited by admin on Sat Dec 16 13:05:26 GMT 2023
|
PRIMARY | |||
|
57524523
Created by
admin on Sat Dec 16 13:05:26 GMT 2023 , Edited by admin on Sat Dec 16 13:05:26 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
